Parental opinions about biomedical research in children in Tours, France.

E Autret, J P Dutertre, P Barbier, A P Jonville, F Pierre, C Berger
{"title":"Parental opinions about biomedical research in children in Tours, France.","authors":"E Autret,&nbsp;J P Dutertre,&nbsp;P Barbier,&nbsp;A P Jonville,&nbsp;F Pierre,&nbsp;C Berger","doi":"10.1159/000457542","DOIUrl":null,"url":null,"abstract":"<p><p>In order to evaluate parental awareness of the law governing clinical trials in France (Loi Huriet), a study was performed by questionnaire between February and April 1991 in a maternity unit during the days following delivery. The response rate was 59%. 59% of the parents (319/541) were informed of the existence of the law by the media (75%) or their general practitioners (12%). Twenty-one percent (116/541) of the parents would accept the participation of their children in a clinical trial and 74% would refuse. The principal reasons for acceptance were: for the benefit of other children, contribution to medical progress and confidence in physicians. The reasons for refusal were: risk of side effects and unproven efficacy. Parents who would accept had more often received higher education (44%) than parents who would refuse (30%), the latter being less influenced by the explanations of physicians and less willing to accept that a physician should decide for them. Physicians should consider transmitting information directly to parents and indirectly via the media.</p>","PeriodicalId":11160,"journal":{"name":"Developmental pharmacology and therapeutics","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"1993-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000457542","citationCount":"25","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Developmental pharmacology and therapeutics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1159/000457542","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 25

Abstract

In order to evaluate parental awareness of the law governing clinical trials in France (Loi Huriet), a study was performed by questionnaire between February and April 1991 in a maternity unit during the days following delivery. The response rate was 59%. 59% of the parents (319/541) were informed of the existence of the law by the media (75%) or their general practitioners (12%). Twenty-one percent (116/541) of the parents would accept the participation of their children in a clinical trial and 74% would refuse. The principal reasons for acceptance were: for the benefit of other children, contribution to medical progress and confidence in physicians. The reasons for refusal were: risk of side effects and unproven efficacy. Parents who would accept had more often received higher education (44%) than parents who would refuse (30%), the latter being less influenced by the explanations of physicians and less willing to accept that a physician should decide for them. Physicians should consider transmitting information directly to parents and indirectly via the media.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
父母对法国图尔儿童生物医学研究的看法。
为了评价父母对法国临床试验法律的认识,1991年2月至4月期间,在分娩后的几天内在一家产科病房进行了问卷调查。应答率为59%。59%的父母(319/541)通过媒体(75%)或他们的全科医生(12%)得知了法律的存在。21%(116/541)的父母会接受他们的孩子参加临床试验,74%的父母会拒绝。接受的主要原因是:为了其他儿童的利益、对医学进步的贡献和对医生的信任。拒绝的原因是:副作用的风险和未证实的疗效。接受治疗的父母(44%)比拒绝治疗的父母(30%)受教育程度更高,后者不太受医生解释的影响,也不太愿意接受医生应该为他们做决定。医生应考虑直接向家长或通过媒体间接传递信息。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Analgesia and sedation in neonatal intensive care using fentanyl by continuous infusion. Effect of calcium channel agonist (BAY K8644) on volatile anesthetic-mediated depression in neonatal rabbit papillary muscle. Mechanisms of increased sensitivity to A2 adenosine receptor stimulation in immature rabbit aortic rings. Pharmacokinetics of paracetamol in the neonate and infant after administration of propacetamol chlorhydrate. Population pharmacokinetics of ceftizoxime in premature newborns.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1